DMM Disease Models and Mechanisms

SJR Rank #3,135H-index: 120SJR: 1.306Best quartile: Q1Open AccessAPC: US$3,750Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Company of Biologists Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.40.81.21.6

Subject Categories

  • Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1
  • Immunology and Microbiology (miscellaneous)Q1
  • Medicine (miscellaneous)Q1
  • Neuroscience (miscellaneous)Q1

Areas: Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · Neuroscience

Most published research topics

Muscle Physiology and DisordersZebrafish Biomedical Research ApplicationsMitochondrial Function and PathologyGenetic Neurodegenerative DiseasesCongenital heart defects researchCRISPR and Genetic EngineeringGenetics, Aging, and Longevity in Model OrganismsNeurogenetic and Muscular Disorders ResearchEpigenetics and DNA MethylationAdipose Tissue and Metabolism

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025055110165220

Detailed Information

ISSN

1754-8403, 1754-8411

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

2.61

References per Document

53.84

Coverage

2008-2026

Scope

Disease Models & Mechanisms (DMM) publishes original research, resources and invited reviews that focus on the use of model systems to better understand, diagnose and treat human disease. The primary aim of DMM is to promote human health by inspiring collaboration between basic and clinical researchers in translational science. The journal is committed to presenting highly significant research that meets this goal. The interdisciplinary nature of DMM means that a diverse range of diseases, approaches and models fall within its scope. Examples of DMM content: -Basic research that significantly advances our understanding of human disease mechanisms, diagnosis or treatment, and is of broad relevance -Drug screens and preclinical analyses of candidate therapies using model systems -Presentation of new models that have been thoroughly validated to demonstrate their utility in disease studies* -New methods and resources that provide broadly useful tools for a disease and/or model community -Comprehensive, expert reviews and posters addressing current and emerging themes in biomedical science -Interviews with leading scientists in translational research -Editorials that discuss wider issues of interest to the community, including regulatory, ethical and policy issues -Special collections that collate articles relating to a particular disease area or model system *Descriptive work, such as the characterisation of a model system without demonstration of its usefulness to advance a field, is generally not considered for publication, unless the new model itself is considered by the Editorial team to provide an improved understanding of the disease mechanism and/or to demonstrate clear usefulness for the evaluation of treatment approaches.

Metrics from SCImago Journal Rank 2025. View on SCImago